Innovative Dextran-Based Conjugates for Targeted Cancer Therapy

• The project aims to enhance targeting efficiency through the use of dextran, a water-soluble, biocompatible polysaccharide with a three-dimensional structure and high loading capacity for drugs and targeting agents.
• Currently, research is underway on conjugation technology. Upon completion, specific therapeutic targets will be selected.